Literature DB >> 6996126

Diabetic heart disease.

A C Asmal, W P Leary, F Thandroyen.   

Abstract

The fact that a significant proportion of diabetics die of heart disease has led to the belief that the excess mortality is due to coronary athersclerosis, yet many risk factors for the latter are common to diabetics and non-diabetics. In fact, heart disease in diabetes is not synonymous with coronary heart disease. There is evidence that heart disease in diabetes includes a variable combination of coronary atheroma, cardiomyopathy, micro-angiopathy and autonomioc neuropathy.

Entities:  

Mesh:

Year:  1980        PMID: 6996126

Source DB:  PubMed          Journal:  S Afr Med J


  10 in total

Review 1.  The role of CaMKII in diabetic heart dysfunction.

Authors:  Lorna Daniels; James R Bell; Lea M D Delbridge; Fiona J McDonald; Regis R Lamberts; Jeffrey R Erickson
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

2.  Diabetes decreases mRNA levels of calcium-release channels in human atrial appendage.

Authors:  Sahika Guner; Ebru Arioglu; Aydin Tay; Atalay Tasdelen; Sait Aslamaci; Keshore R Bidasee; U Deniz Dincer
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

3.  Coronary blood flow in chronic insulin-dependent diabetic dogs.

Authors:  K W Small; E Stefansson; D L Hatchell
Journal:  Acta Diabetol Lat       Date:  1989 Oct-Dec

4.  Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts.

Authors:  Keshore R Bidasee; Karuna Nallani; Bruce Henry; U Deniz Dincer; Henry R Besch
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

5.  Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.

Authors:  Vasundhara Kain; Sandeep Kumar; Sandhya L Sitasawad
Journal:  Cardiovasc Diabetol       Date:  2011-11-04       Impact factor: 9.951

Review 6.  Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways.

Authors:  Jason Kar Sheng Lew; James T Pearson; Daryl O Schwenke; Rajesh Katare
Journal:  Cardiovasc Diabetol       Date:  2017-01-13       Impact factor: 9.951

7.  Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells.

Authors:  Ingrid Fomison-Nurse; Eugene Eng Leng Saw; Sophie Gandhi; Pujika Emani Munasinghe; Isabelle Van Hout; Michael J A Williams; Ivor Galvin; Richard Bunton; Philip Davis; Vicky Cameron; Rajesh Katare
Journal:  Cell Death Differ       Date:  2018-01-04       Impact factor: 15.828

Review 8.  MicroRNAs as biomarkers for monitoring cardiovascular changes in Type II Diabetes Mellitus (T2DM) and exercise.

Authors:  Volga M Saini; Kaitlyn R Liu; Aishwarya Suryakant Surve; Sanjeev Gupta; Ananya Gupta
Journal:  J Diabetes Metab Disord       Date:  2022-07-07

Review 9.  Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease.

Authors:  Shruti Rawal; Patrick Manning; Rajesh Katare
Journal:  Cardiovasc Diabetol       Date:  2014-02-14       Impact factor: 9.951

10.  Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes.

Authors:  Kwong-Man Ng; Yee-Man Lau; Vidhu Dhandhania; Zhu-Jun Cai; Yee-Ki Lee; Wing-Hon Lai; Hung-Fat Tse; Chung-Wah Siu
Journal:  Sci Rep       Date:  2018-10-05       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.